UK/NETHERLANDS â€" A group of pension funds has told pharmaceutical firms they need more information about the industry’s emerging market strategies.
The £22bn Universities Superannuation Scheme and the €175bn APG Investments – which administers government and educational scheme investments in the Netherlands – said long-term investment o...
To continue reading this article...
Join Professional Pensions
Become a Professional Pensions Lite Member today
In just a few clicks you can start your free Professional Pensions Lite membership for 12 months, providing you access to:
- Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
- Receive important and breaking news stories via our two daily news alerts
- Hear from industry experts and other forward-thinking leaders
Are you a trustee, investment consultant or in-house pension and benefit scheme professional? You can apply for full complimentary access here
